In the fourth-quarter ended December 2014, AbbVie Inc. [NYSE:ABBV] reported adjusted revenues of $5.37 billion, up 5.1% year-over-year, including a 3.8% unfavorable impact
...
In the fourth-quarter ended December 2014, Celgene Corp. [NASDAQ:CELG] reported total revenues of $2.09 billion, up 18.74% year-over-year and EPS with ex-items of
$1.01
...
In the fourth-quarter ended December 2014, Biogen Idec
[NASDAQ:BIIB] reported total revenues of $2.64 billion, up 34% year-over-year and EPS with ex-items of $4.09, up
...
Last Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie's
[NYSE:ABBV] VIEKIRA PAK, an all-oral hepatitis C drug. The VIEKIRA PAK will cost U.S. $83,319
...
Yesterday, Biogen Idec [NASDAQ: BIIB] announced that they would move BIIB037 (human anti-amyloid beta mAb) to Phase III for Alzheimer’s disease, based on its promising Phase I results. The drug has shown to reduce amyloid plaque in
...
Actavis reported Q3 2014 earnings of $3.19 per share, up 52.6% from a year-ago, and revenues increased 83% to $3.7 billion. The results include those from Forest Labs, acquired in July 2014, and Warner
Chilcott, acquired in October 2013
...
Jazz Pharmaceuticals
[NASDAQ:JAZZ] reported Q3 2014 adjusted earnings of $2.33 per share, up 30.9% from a year-ago and revenues increased 32% to $306.6
million ...
Regeneron Pharmaceuticals reported Q3 2014 earnings of $2.52 per share, up 6% from a year-ago. The earnings included a $34 million charge, or $0.29 per share, for its
...
Stem
cell research continues to be a major news topic with many
reports indicating strong public support for the advancement of
stem cell research. While universities ...
To prevent and treat inflammatory and autoimmune disorders, cancer, rheumatoid arthritis and infectious diseases, biotech and biopharmaceutical companies are using monoclonal
...
Multiple Sclerosis (MS) is a disease that affects the central nervous system. MS is believed by most researchers to be an autoimmune disease in which the immune system
...
Multiple Sclerosis (MS) is a disease that affects the central nervous system. MS is believed by most researchers to be an autoimmune disease in which the immune system
...
According to the U.S. National Center for Health Statistics [1], heart disease, malignant neoplasms (cancer) and cerebrovascular diseases (stroke) are the three leading
...
During
the past few years, new and innovative developments of
nanospheres and nanoparticles for drug delivery systems
and life science applications have been reported [1-2].
This ...
The 40th Annual Meeting of the American Society of Clinical Oncology
(ASCO), where the world's leading professionals meet and present results on topics from lung cancer and
...
